Acrivon Therapeutics, Inc. (ACRV) insider trading
Over the last 12 months, 3 insiders bought $115K and 6 insiders sold $40.4K of Acrivon Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Oct 5, 2026: Miller Mary sold 294 shares ($585)
- Aug 25, 2026: Blume-Jensen Peter sold 14,036 shares ($31.0K)
- Aug 18, 2026: Blume-Jensen Peter sold 1,713 shares ($3.44K)
- Aug 18, 2026: Devroe Eric sold 604 shares ($1.21K)
- Aug 18, 2026: Gamelin Erick sold 400 shares ($804)
- Aug 18, 2026: Miller Mary sold 185 shares ($372)
- Aug 18, 2026: Peterson Katharine sold 101 shares ($203)
- Aug 4, 2026: Levy Adam D. sold 1,142 shares ($1.79K)
- Jul 21, 2026: Miller Mary sold 573 shares ($1.01K)
- Jan 14, 2026: Levy Adam D. bought 8,832 shares ($15.0K)